Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 35
- Pharmaceutical
DLA Piper advises on £80m acquisition
Canaccord Genuity was advised on Summerway Capital Plc’s AIM listing.
- Companies
Inflation: is it affecting the cannabis market?
Inflation is at a record high, but cannabis prices are continuing to fall.
- Hemp Industry
Tony Reeves of EIHA: cannabis has been an exciting journey
European Industrial Hemp Association (EIHA) board member Tony Reeves discusses his journey into cannabis.
- Companies
GROW’s expansion placing the cannabis company as a leader in Europe
Its unique position will set GROW apart from other players in the European market.
- Companies
Celadon move represents landmark AIM listing
Having acquired Vertigrow Technology in a deal valuing it at around £80m, AIM cash shell Summerway Capital has renamed as Celadon Pharmaceuticals.
- Pharmaceutical
GW Pharma begins constructing £75m UK cannabis manufacturing facility
GW Pharmaceuticals’ facility will create more than “100 highly skilled jobs”.
- Companies
What does Kanabo’s telehealth approach mean for UK medical cannabis?
Kanabo surprised the market with its £14m acquisition of the GP Service – so, what does this mean for the UK industry and patients?
- Companies
Alpha Blue Ocean puts more capital in cannabis
The financing will support Halo Collective’s US west coast expansion strategy.
- Companies
Akanda: first UK company listing on NASDAQ with African operations
The company will trade under the ticker AKAN.
- Hemp Industry
Canxchange Q1 2022 benchmark report explores hemp market outlook
The Canxchange Farmers Sentiment Index (CFSI) overall has “collapsed” from its July high.
- CBD Market
The power of purpose in the cannabis industry
CEO of Medical Marijuana Inc, Blake Schroeder, wants to change the world with cannabis.
- Pharmaceutical
Major shareholder appeals for urgent change at Oxford Cannabinoid Technologies
The appeal states there is an urgent need to address serious governance and sclerotic management issues.
